No Data
Moderna, Sarepta, Biotech Stocks Sink After Top FDA Official Resigns
Top Gap Ups and Downs on Monday: MUFG, UBS, MFG and More
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
U.S. stock market fluctuations | A well-known FDA official resigned, causing Moderna (MRNA.US) to drop nearly 9%.
Vaccine giant Moderna and gene therapy company Sarepta Therapeutics fell nearly 9%, reporting prices of $28.34 and $64.09 respectively.
Sarepta Downgraded at RBC Capital on Gene Therapy Concerns
Vaccine Stocks Fall After Ousting of FDA's Vaccine Head
